The Key to A Cure for Food Allergies
Tackling Food Allergy at the Molecular Network Level

The Key to A Cure for Food Allergies

Spring has officially sprung! Birds are chirping, and flowers and trees are budding and blooming. It's the time of year when many people experience symptoms from seasonal allergies including sneezing and congestion and other bothersome symptoms.

Spring is also the time of year where we put a spotlight on food allergy in support of the 32 million Americans who are living with potentially life-threatening food allergies, including 5.6 million children, or two in every classroom. In fact, here in New England, Governor Charlie Baker will issue a proclamation declaring May 8th - 14th, 2022 to be Food Allergy Awareness Week throughout the entire Commonwealth.

Every three minutes, a food allergy reaction sends someone to the emergency room. A?food allergy?occurs when the body’s immune system sees a certain food as harmful and reacts by causing symptoms such as hives and vomiting, or even anaphylaxis, which is a life-threatening allergic reaction involving tightening of the airways, swelling of the throat, severely low blood pressure and shock.

Although new treatments are being developed, unfortunately there is no cure for food allergies. According to renowned scientist and computational biologist Aviv Regev, PhD , we know too little about the basic biological mechanisms that underlie these allergies "food allergies is a field we know remarkably little about."

Fortunately there is hope on the horizon! The Food Allergy Science Institute (FASI) was launched at The Broad Institute of MIT and Harvard in 2016 and was spun out in 2021 as an independent nonprofit organization. The mission of FASI is unique, but simple: to accelerate cross-discipline scientific research to develop a cure for food allergy.

FASI is 100% research driven -- they do nothing else but researching food allergy. FASI is a pure discovery engine, a one-of-a-kind scientific network with talent and resources spanning a dozen academic research institutions including The Broad Institute of MIT and Harvard, Yale, Rockefeller University, and The Icahn School of Medicine.

Many people are familiar with FARE (Food Allergy Research & Education) which is a wonderful resource for people and families navigating the world of food allergies. FARE's initiatives include food allergy advocacy, education and training programs, awareness campaigns, and research. FASI's differentiators?include a 100% focus on research with 100% of philanthropic donations directly support FASI's groundbreaking research, and the key to a cure is research.

FASI's other differentiator is it's cross-disciplinary approach which breaks down silos and promotes scientific collaboration and innovation in developing transformative treatments and ultimately a cure for food allergy. FASI represents a paradigm shift in how the entire field of food allergy is approached and includes some of the greatest scientific minds in the world coordinated across diverse fields from immunology and?neuroscience to computational biology and engineering to uncover gaps in scientific knowledge and get closer to a cure.

FASI is led by its Co-Founder and CEO, Christine Olsen, MD , a radiation oncologist at Massachusetts General Hospital and a clinical instructor at Harvard Medical School (in addition to being the mom of a child with food allergy), and its Chief Scientific Officer, Ruslan Medzhitov, PhD , Sterling Professor of Immunobiology at Yale University School of Medicine, and a Howard Hughes Medical Institute investigator.

"As FASI’s director, it’s my mission to ensure that food allergy research gets the scientific attention it deserves, so we can together advance the field and work toward effective treatments and therapeutics that patients urgently need. To develop a cure, we need to understand the disease, and to understand the disease, we need to know its normal biological counterpart. Every disease is an abnormal version of some biological function. -- Ruslan Medzhitov, PhD

FASI has uncovered a major new theory and research direction – the role of the nervous system in food allergies. By increasing our understanding of the?connection between the nervous system and the immune system, FASI's hope is to reverse our bodies from interpreting a food as a noxious substance to understanding that it’s safe for us to consume.

“Millions of patients are waiting for food allergy diagnosis and treatment breakthroughs, as the speed of scientific learning about these conditions has been eclipsed by the growth of food allergies in the population. FASI seeks to accelerate the drug discovery needed to halt this epidemic and enable children and adults living with food allergies to realize improved quality of life, one free from the constant threat of reactions that can include anaphylaxis.” -- Chris Olsen, MD

I'm hoping that you are as excited about FASI as I am, the nation's first cross-disciplinary research nonprofit organization that's 100% dedicated to food allergy research. If you are an investigator interested in joining the FASI network, please reach out and I'll put you in touch! And since FASI is funded by philanthropic donations to support its groundbreaking research, please consider some of the options I outlined below.

HOW TO SUPPORT FOOD ALLERGY SCIENCE:

For major donors, corporate donors, and foundations, please email Kate Todd?[email protected] ?

Individual donors may make a charitable donation to support FASI's research:? https://foodallergyscience.org/make-a-donation/ ?

Connect with FASI on social media to follow the latest food allergy research: @Twitter ,?@LinkedIn ?and?@Facebook


Heidi Creighton

CEO, Creighton HealthTech | Life Sciences | Genomics | GenAI | Digital Health | LinkedIn Group Admin: Spatial Biology Pioneers, Generative AI in Life Sciences & Healthcare, Digital Therapeutics (DTx) Network

2 年
回复

要查看或添加评论,请登录

Heidi Creighton的更多文章

  • Generative AI Speeds Life Sciences Communications

    Generative AI Speeds Life Sciences Communications

    Generative AI is a phenomenal communications tool that helps improve and accelerate work for clients and corporations…

    1 条评论
  • Communicating in Biotech During COVID

    Communicating in Biotech During COVID

    The life sciences has been and continues to be squarely in the spotlight during the COVID-19 pandemic, with startups…

    3 条评论
  • The Little Things

    The Little Things

    After 2020 and 2021 where our home and work lives were disrupted and transformed, where COVID-19 became the talk of the…

  • A Path to a Cure for Food Allergies

    A Path to a Cure for Food Allergies

    This week, Governor Charlie Baker issued a proclamation declaring May 9th -15th, 2021 to be "Food Allergy Awareness…

  • Boston is Mecca for Coronavirus Solutions, Innovations

    Boston is Mecca for Coronavirus Solutions, Innovations

    Boston & the Bay State are leaders in battling the coronavirus and flattening the curve. The Massachusetts science…

    1 条评论
  • Go Back to Work and School

    Go Back to Work and School

    By Heidi Creighton The world is in the midst of an unprecedented pandemic. Anxiety, fear, and panic are increasing with…

    1 条评论
  • No Borders, No Walls Can Stop Coronavirus from Spreading Across U.S.

    No Borders, No Walls Can Stop Coronavirus from Spreading Across U.S.

    By Heidi Creighton This evening, President Trump will hold a press conference at the White House at 6:00 PM ET on the…

  • Patient Safety in a Digital World

    Patient Safety in a Digital World

    The First Annual International Patient Safety Symposium is set to launch on January 28, 2020 at Dana-Farber Cancer…

  • Digital Health Impact 2019

    Digital Health Impact 2019

    Digital transformation is impacting every industry across the globe -- BFSI, Telecom & IT, Healthcare, Automotive…

    1 条评论
  • Level-headed Leadership: It's What America Needs, and Deserves

    Level-headed Leadership: It's What America Needs, and Deserves

    The future of America will be determined by the outcome of the 2020 Presidential Election, and I have chosen to share…

社区洞察